Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8410112 Compounds useful as inhibitors of ATR kinase

Patent 8410112 was granted and assigned to Vertex Pharmaceuticals on April, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Vertex Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

84101120

Patent Inventor Names

Jean-Damien Charrier0

Alina Silina0

Anisa Nizarali Virani0

David Kay0

Dennis James Hurley0

Hayley Marie Binch0

Steven John Durrant0

Thomas Cleveland0

...

Date of Patent

April 2, 2013

Patent Application Number

131042910

Date Filed

October 27, 2011

Patent Citations Received

‌

US Patent 11787781 Inhibiting ataxia telangiectasia and RAD3-related protein (ATR)

‌

US Patent 11926616 Aminopyrazine diol compounds as PI3K-γ inhibitors

Patent Primary Examiner

‌

Erich A Leeser

Patent abstract

The present disclosure relates to pyrazine compounds of formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8410112 Compounds useful as inhibitors of ATR kinase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API